fluoxetine has been researched along with AIDS Seroconversion in 11 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ambulatory HIV-seropositive women with DSM-IV depressive disorders were enrolled in an 8-week, open trial of fluoxetine (N = 21) or sertraline (N = 9) initiated at standard dosages." | 5.09 | Antidepressant treatment of depression in HIV-seropositive women. ( de Moore, GM; Ferrando, SJ; Rabkin, JG; Rabkin, R, 1999) |
| "Patients were recruited from the UCLA AIDS Research Center who had previously been referred to psychiatry for participation in an open-label pilot treating patients with major depression with fluoxetine." | 3.68 | Group psychotherapy for HIV-seropositive patients with major depression. ( Baron, D; Bystritsky, A; Jones, LD; Levine, SH, 1991) |
| "Fluoxetine is an effective antidepressant in the context of HIV illness." | 2.69 | Fluoxetine treatment for depression in patients with HIV and AIDS: a randomized, placebo-controlled trial. ( Rabkin, JG; Rabkin, R; Wagner, GJ, 1999) |
| "Informing drug abusers in treatment regarding positive HIV-serostatus was not associated with a lower treatment-retention rate or adverse psychological reactions when counseling regarding HIV issues was integrated with drug abuse treatment." | 2.67 | Psychological reactions and retention by cocaine addicts during treatment according to HIV-serostatus: a matched-control study. ( Brown, BS; Haertzen, CA; Hess, JM; Weddington, WW, 1991) |
| "Fluoxetine treatment may be effective in treating major depression in HIV-seropositive asymptomatic patients." | 1.28 | A report of eight HIV-seropositive patients with major depression responding to fluoxetine. ( Anderson, D; Baron, D; Bystritsky, A; Levine, S, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 10 (90.91) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Giroud, C | 1 |
| Michaud, K | 1 |
| Sporkert, F | 1 |
| Eap, C | 1 |
| Augsburger, M | 1 |
| Cardinal, P | 1 |
| Mangin, P | 1 |
| Rabkin, JG | 4 |
| Rabkin, R | 3 |
| Wagner, G | 1 |
| Wagner, GJ | 2 |
| Maguen, S | 1 |
| Zisook, S | 2 |
| Peterkin, J | 1 |
| Goggin, KJ | 1 |
| Sledge, P | 1 |
| Atkinson, JH | 1 |
| Grant, I | 1 |
| Cazzullo, CL | 1 |
| Bessone, E | 1 |
| Bertrando, P | 1 |
| Pedrazzoli, L | 1 |
| Cusini, M | 1 |
| Ferrando, SJ | 1 |
| de Moore, GM | 1 |
| Weddington, WW | 1 |
| Haertzen, CA | 1 |
| Hess, JM | 1 |
| Brown, BS | 1 |
| Levine, SH | 1 |
| Bystritsky, A | 2 |
| Baron, D | 2 |
| Jones, LD | 1 |
| Levine, S | 1 |
| Anderson, D | 1 |
| Hintz, S | 1 |
| Kuck, J | 1 |
| Peterkin, JJ | 1 |
| Volk, DM | 1 |
7 trials available for fluoxetine and AIDS Seroconversion
| Article | Year |
|---|---|
Effects of fluoxetine on mood and immune status in depressed patients with HIV illness.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Affect; Aged; CD4-Positive T-Lymphocytes; Dep | 1994 |
Ethnic differences in response to fluoxetine in a controlled trial with depressed HIV-positive patients.
Topics: Adult; Depressive Disorder; Female; Fluoxetine; HIV Seropositivity; Humans; Male; Middle Aged; Racia | 1998 |
Treatment of major depression in HIV-seropositive men. HIV Neurobehavioral Research Center Group.
Topics: Adult; Combined Modality Therapy; Comorbidity; Depressive Disorder; Double-Blind Method; Drug Admini | 1998 |
Treatment of depression in HIV-infected patients.
Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Female; Fluoxetine; HIV Seropo | 1998 |
Fluoxetine treatment for depression in patients with HIV and AIDS: a randomized, placebo-controlled trial.
Topics: Acquired Immunodeficiency Syndrome; Adult; CD4 Lymphocyte Count; Depressive Disorder; Double-Blind M | 1999 |
Antidepressant treatment of depression in HIV-seropositive women.
Topics: Ambulatory Care; Antidepressive Agents; Comorbidity; Depressive Disorder; Female; Fluoxetine; HIV Se | 1999 |
Psychological reactions and retention by cocaine addicts during treatment according to HIV-serostatus: a matched-control study.
Topics: Adaptation, Psychological; Adult; Affect; AIDS Serodiagnosis; Amantadine; Baltimore; Cocaine; Combin | 1991 |
4 other studies available for fluoxetine and AIDS Seroconversion
| Article | Year |
|---|---|
A fatal overdose of cocaine associated with coingestion of marijuana, buprenorphine, and fluoxetine. Body fluid and tissue distribution of cocaine and its metabolites determined by hydrophilic interaction chromatography-mass spectrometry(HILIC-MS).
Topics: Analgesics, Opioid; Biotransformation; Buprenorphine; Cannabinoids; Chromatography, Liquid; Cocaine; | 2004 |
Group psychotherapy for HIV-seropositive patients with major depression.
Topics: Adaptation, Psychological; Adolescent; Adult; AIDS-Related Complex; Combined Modality Therapy; Depre | 1991 |
A report of eight HIV-seropositive patients with major depression responding to fluoxetine.
Topics: Adult; Depressive Disorder; Female; Fluoxetine; Follow-Up Studies; HIV Seropositivity; Humans; Male; | 1990 |
Depression in the context of human immunodeficiency virus infection: implications for treatment.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Complex; Antidepressive Agents; Depressive D | 1990 |